Moreover, the SMYD3 inhibitor BCI-121, which is utilized to treat endometrial cancer, attenuates the tumorigenicity of endometrial cancer and improves the efficacy of radiotherapy71. The gene discussed is SMYD3; the disease is endometrial cancer.